This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates targeting central nervous system disorders. Its unique stereochemistry and structural features make it a valuable intermediate in the creation of potent and selective receptor modulators. It is often employed in the design of molecules aimed at treating conditions such as depression, anxiety, and chronic pain. Additionally, its trifluoromethyl and fluorophenyl groups contribute to enhanced metabolic stability and binding affinity, making it a key component in optimizing pharmacokinetic properties of therapeutic agents. Researchers also explore its potential in developing treatments for inflammatory diseases due to its ability to interact with specific biological pathways.